Chemotherapy of systemic mycoses (first of two parts).
D000666:Amphotericin B / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use*; D000818:Animals; D001639:Bicarbonates / Q000008:administration & dosage / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006801:Humans; D007263:Infusions, Parenteral; D007270:Injections, Intra-Articular; D007275:Injections, Intravenous; D007278:Injections, Spinal; D007668:Kidney / Q000187:drug effects; D008353:Mannitol / Q000008:administration & dosage / Q000627:therapeutic use; D008581:Meningitis / Q000188:drug therapy; D009181:Mycoses / Q000188:drug therapy*; D012293:Rifampin / Q000008:administration & dosage / Q000627:therapeutic use
D001639:Bicarbonates; D008353:Mannitol; D000666:Amphotericin B; D012293:Rifampin